HomePharmaceutical

Pharmaceutical

Why Psychedelics Could Soon Replace Antidepressants

Why Psychedelics Could Soon Replace Antidepressants

April 13, 2022

Demand for Toad Venom Rises Along With the Booming Psychedelics Market

Demand for Toad Venom Rises Along With the Booming Psychedelics Market

March 30, 2022

Pharmacy Giant Files Patent to Join the Metaverse

Pharmacy Giant Files Patent to Join the Metaverse

March 23, 2022

Psilocybin and MDMA Get the Green Light for Medical Use in Canada

Psilocybin and MDMA Get the Green Light for Medical Use in Canada

January 19, 2022

Purdue Pharma Explores Bankruptcy After Thousands of Lawsuits

Purdue Pharma Explores Bankruptcy After Thousands of Lawsuits

March 4, 2019

JNJ Stock: Johnson & Johnson Misses Analyst Target for Forecast 2019 Sales

JNJ Stock: Johnson & Johnson Misses Analyst Target for Forecast 2019 Sales

January 22, 2019

23andMe Gives Customer Data to GlaxoSmithKlein

23andMe Gives Customer Data to GlaxoSmithKlein

August 3, 2018

CTD Holdings Conducts Initial Review of Safety Data for its Phase I and Phase I/II Trials of Trappsol(R) Cyclo(TM) to Treat Niemann-Pick Disease Type C

CTD Holdings Conducts Initial Review of Safety Data for its Phase I and Phase I/II Trials of Trappsol(R) Cyclo(TM) to Treat Niemann-Pick Disease Type C

March 29, 2018

Teva Pharmaceutical Reports Drop in Q3 Profit, Shares Plunge Almost 18%

Teva Pharmaceutical Reports Drop in Q3 Profit, Shares Plunge Almost 18%

November 2, 2017

3 Reasons Behind Celgene Corp.’s Abysmal Q3 Earnings Report

3 Reasons Behind Celgene Corp.’s Abysmal Q3 Earnings Report

October 30, 2017

1 2 3 »